ECNP-PsychX talks

Bringing you the latest science in psychiatry

About PsychX and ECNP
Mental health expertise should be more accessible. This is the belief of Christiaan Vinkers, Jurjen Luykx, Frank Gerritse (psychiatrists and researchers) and Dido Prins (psychiatry resident). It resulted in launching PsychX, to give a platform to young as well as more experienced scientists working in mental health. PsychX has been providing you with monthly short online talks on a range of mental health topics. These talks are easy to access, with no registration or costs involved.

In 2022, PsychX and ECNP started collaborating. As from 2023, all PsychX talks will be transferred to ECNP. The concept of the talks stays the same: free, online talks with a Q&A where you can discuss your thoughts with the speaker directly.

These talks are free, online, monthly presentations with Q&A about a range of topics in clinical and more research-oriented psychiatry.

How to join
Direct meeting link: https://zoom.us/j/94455299847?pwd=OFBlcjVucjhmWWpLbGxtL054aitWQT09
Meeting ID: 854 0080 8569
Passcode: PSYCHX
One tap mobile: +31207946520,,94455299847#,,,,630530# Netherlands +31207947345,,94455299847#,,,,630530# Netherlands

To prevent connection issues, please use the Zoom-app instead of the website. 

Scheduled talks
These are the free online talks we have scheduled for 2023, every first Monday of the month at 16.30 -17.30 CET (Central European Time).

Monday 5 June 2023
The exposome paradigm to understand the environmental origins of mental disorders
Sinan Guloksuz

Sinan Guloksuz, MD, PhD is an associate professor of psychiatry at the department of psychiatry and neuropsychology, School for Mental Health and Neuroscience, Maastricht University, and the epartment of psychiatry, Specialized Treatment Early in Psychosis (STEP) Program, Yale University School of Medicine. With a background in clinical psychiatry and epidemiology, Guloksuz’s main research focus has been on understanding the mechanisms underlying mental health outcomes and investigating the contribution of exposome and genome to multidimensional phenotypes in the general population cohorts and large case-control samples. The second body of his work has been in the areas of clinical trials and service research for psychosis spectrum disorder. His work has resulted in over 120 peer-reviewed publications, 12 book chapters, and awarded with international prizes. He has ongoing active roles in professional organisations, such as the Schizophrenia International Research Society and currently serves as the associate editor of the npj Mental Health Research and the editorial board member of the British Journal of Psychiatry and the PLOS One.

Monday 4 September 2023
Topic and speaker to be announced

Monday 6 November 2023
Topic to be announced
Laura Berner

Monday 4 December 2023
Topic and speaker to be announced

Date to be announced
Topic to be announced
Rene Kahn

René Kahn is chair of psychiatry at the Icahn School of Medicine at Mount Sinai since 2017. After completing medical school in the Netherlands, he was trained as a psychiatrist and neurologist in Utrecht and Amsterdam. He subsequently completed his psychiatry residencies at Mount Sinai Hospital and then worked as chief of the psychiatry research unit at the Bronx VA. In 1993 he became chair of psychiatry at the University Hospital Utrecht, going on to lead the Brain Center Rudolf Magnus, which combines research in basic neuroscience, psychiatry and neurology. Kahn has published over 950 research papers with a web of science H index of 107. He has been continuously funded for over 25 years by NIMH, the EU, the Stanley Foundation, and other organisations. He has served on several neuroscience grant review boards. René Kahn received several honors, such as a Fulbright Scholarship, membership of the Royal Netherlands Academy of Arts and Sciences, the ECNP Neuropsychopharmacology Award, an honorary doctorate at Semmelweis University in Budapest, Hungary and the lifetime achievement award of the Netherlands Psychiatric Association. He was knighted in the Netherlands in 2018. He served as treasurer and vice-president of ECNP and as president of the Schizophrenia International Research Society. He is a fellow of the American College of Neuropsychopharmacology.

Previous talks
View here previous PsychX talks.